GlassScriptPhysician profile
Jill M Trelease
NPI 1619371747
$2,101.39
in general payments reported to CMS, 2019-2025
15 companies · $800 in 2025
The $800 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $293 · 2022: $352 · 2023: $308 · 2024: $348 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $846.71 | 2021-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Organogenesis INC. | $253.16 | 2024-2025 | Puraply Am, Apligraf, Puraply Franchise |
| Abbvie INC. | $212.47 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $206.82 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $120.23 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $100.50 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $83.82 | 2025 | |
| Kerecis Limited | $72.43 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Convatec INC. | $58.27 | 2021 | |
| Next Science LLC | $48.93 | 2022-2023 | Xperience, Surgx, Blastx |
| Integra Lifesciences Corporation | $24.45 | 2022 | |
| Lifenet Health | $23.51 | 2024 | Theragenesis Wound Matrix |
| Hartmann USA, INC. | $18.21 | 2023 | Zetuvit Plus |
| Medline Industries LP | $16.20 | 2024 | Medline |
| Reprise Biomedical, INC. | $15.68 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Trelease listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.